Dermata Therapeutics logo

Dermata Therapeutics share price today

(DRMA)

Dermata Therapeutics share price is $1.41 & ₹120.99 as on 7 Jan 2025, 2.30 'hrs' IST

$1.41

-0.02

(-1.4%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Dermata Therapeutics share price in Dollar and Rupees. Guide to invest in Dermata Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Dermata Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Dermata Therapeutics share price movements

  • Today's Low: $1.38
    Today's High: $1.48

    Day's Volatility :6.76%

  • 52 Weeks Low: $1.00
    52 Weeks High: $13.35

    52 Weeks Volatility :92.51%

Dermata Therapeutics Returns

PeriodDermata Therapeutics IncIndex (Russel 2000)
3 Months
4.38%
0.0%
6 Months
-41.15%
0.0%
1 Year
-83.56%
0.0%
3 Years
-99.6%
-19.8%

Dermata Therapeutics Key Statistics

in dollars & INR

Previous Close
$1.43
Open
$1.45
Today's High
$1.48
Today's Low
$1.38
Market Capitalization
$2.8M
Today's Volume
$228.7K
52 Week High
$13.35
52 Week Low
$1.0
Revenue TTM
$0.0
EBITDA
$-7.9M
Earnings Per Share (EPS)
$-13.36
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-173.01%

How to invest in Dermata Therapeutics from India?

It is very easy for Indian residents to invest directly in Dermata Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Dermata Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Dermata Therapeutics or DRMA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Dermata Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Dermata Therapeutics shares which would translate to 0.609 fractional shares of Dermata Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Dermata Therapeutics, in just a few clicks!

Returns in Dermata Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Dermata Therapeutics investment value today

Current value as on today

₹19,430

Returns

₹80,570

(-80.57%)

Returns from Dermata Therapeutics Stock

₹83,793 (-83.79%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Dermata Therapeutics

18%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Dermata Therapeutics on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 18% more investors are searching Dermata Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Dermata Therapeutics

  • Tower Research Capital LLC

    0.14%

  • Wells Fargo & Co

    0.10%

  • UBS Group AG

    0.07%

Analyst Recommendation on Dermata Therapeutics

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Dermata Therapeutics(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Dermata Therapeutics

What analysts predicted

Upside of 325.53%

Current:

$1.41

Target:

$6.00

Insights on Dermata Therapeutics

  • Price Movement

    In the last 6 months, DRMA stock has moved down by -39.4%
  • DRMA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 109.7%
  • DRMA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 154.8%

Dermata Therapeutics Technicals Summary

Sell

Neutral

Buy

Dermata Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Dermata Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Dermata Therapeutics Inc
7.52%
-41.15%
-83.56%
-99.6%
-99.89%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Dermata Therapeutics Inc
NA
NA
NA
0.0
-1.73
-0.91
NA
24.25
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Dermata Therapeutics Inc
Buy
$2.8M
-99.89%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Dermata Therapeutics

dermata therapeutics, llc is a research company based out of 12340 el camino real, san diego, california, united states.
Organization
Dermata Therapeutics
Employees
8
CEO
Mr. Gerald T. Proehl
Industry
Miscellaneous

Management People of Dermata Therapeutics

NameTitle
Mr. Gerald T. Proehl
Founder, President, CEO & Chairman
Mr. David F. Hale
Co-Founder & Lead Independent Director
Ms. Kyri K. Van Hoose CPA, M.B.A.
Senior VP & CFO
Dr. Christopher J. Nardo M.P.H., Ph.D.
Senior VP & Chief Development Officer
Mr. Sean Proehl
Senior Director of Legal & Business Development
Dr. Maria Bedoya Toro Munera M.B.A., Ph.D.
Senior Vice President of Regulatory Affairs & Quality Assurance

Important FAQs about investing in Dermata Therapeutics from India :

What is Dermata Therapeutics share price today?

Dermata Therapeutics share price today stands at $1.41, Open: $1.45 ; Previous Close: $1.43 ; High: $1.48 ; Low: $1.38 ; 52 Week High: $13.35 ; 52 Week Low: $1.00. The stock opens at $1.45, after a previous close of $1.43. The stock reached a daily high of $1.48 and a low of $1.38, with a 52-week high of $13.35 and a 52-week low of $1.00.

Can Indians buy Dermata Therapeutics shares?

Yes, Indians can invest in the Dermata Therapeutics (DRMA) from India.

With INDmoney, you can buy Dermata Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Dermata Therapeutics at zero transaction cost.

How can I buy Dermata Therapeutics shares from India?

It is very easy to buy Dermata Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Dermata Therapeutics be purchased?

Yes, you can buy fractional shares of Dermata Therapeutics with INDmoney app.

What are the documents required to start investing in Dermata Therapeutics stocks?

To start investing in Dermata Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Dermata Therapeutics

Today’s highest price of Dermata Therapeutics (DRMA) is $1.48.

Today’s lowest price of Dermata Therapeutics (DRMA) is $1.38.

What is today's market capitalisation of Dermata Therapeutics

Today's market capitalisation of Dermata Therapeutics DRMA is 2.8M

What is the 52 Week High and Low Range of Dermata Therapeutics

  • 52 Week High

    $13.35

  • 52 Week Low

    $1.00

What are the historical returns of Dermata Therapeutics?

  • 1 Month Returns

    7.52%

  • 3 Months Returns

    -41.15%

  • 1 Year Returns

    -83.56%

  • 5 Years Returns

    -99.89%

Who is the Chief Executive Officer (CEO) of Dermata Therapeutics

Mr. Gerald T. Proehl is the current Chief Executive Officer (CEO) of Dermata Therapeutics.